Literature DB >> 12175856

Modulation of glial glutamate transport through cell interactions with the extracellular matrix.

Zu-Cheng Ye1, Harald Sontheimer.   

Abstract

Glial glutamate transport plays a pivotal role in maintaining glutamate homeostasis in the central nervous system. Expression of glutamate transporters is highly regulated during brain development, and a number of pathological conditions are associated with deficits in expression and/or function of glutamate transports. While several soluble factors have been shown to regulate the expression of glutamate transporter, the contribution of cell-cell interaction and cell-environmental interaction in the regulation of glutamate transport is unknown. Extracellular matrix (ECM) molecules are essential components in cell-cell and cell-environmental interactions, and the ECM has been shown to play critical role in normal development and during brain pathogenesis. We, therefore, investigated the possibility that ECM molecules may regulate astrocytic glutamate transport. Therefore, we cultured rat cortical astrocytes with different ECMs and determined expression levels of the two astrocytic glutamate transporters GLT-1 and GLAST by Western Blot and determined transporter activity through measurements of 3H-D-aspartate uptake. Astrocytes grown on poly-ornithine or poly-D/L-lysine showed approximately two-fold higher GLT-1 expression than sister cells grown on plastic dishes without ECM. Naturally occurring ECM's, including laminin and collagen, showed a dose-dependent regulation of GLT-1 protein expression. These effects were specific for GLT-1 as GLAST expression was unaffected by different ECMs. Surprisingly, however, none of the examined ECMs altered the apparent glutamate uptake activity. In probing blots side-by-side for expression of Na(+)/K(+)-ATPase, we found that ECMs affected expression of Na(+)/K(+)-ATPase and GLT-1 in a reciprocal fashion. Poly-ornithine, for example, enhanced GLT-1 expression, but reduced expression of Na(+)/K(+)-ATPase. Na(+) transport may, thus, be a limiting factor for glutamate uptake.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175856     DOI: 10.1016/s0736-5748(02)00048-5

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  6 in total

1.  Cellular changes underlying hyperoxia-induced delay of white matter development.

Authors:  Thomas Schmitz; Jonathan Ritter; Susanne Mueller; Ursula Felderhoff-Mueser; Li-Jin Chew; Vittorio Gallo
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

2.  Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds.

Authors:  Jessica A DeQuach; Shauna H Yuan; Lawrence S B Goldstein; Karen L Christman
Journal:  Tissue Eng Part A       Date:  2011-10-17       Impact factor: 3.845

3.  Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes.

Authors:  Logan C Meyer; Caitlin E Paisley; Esraa Mohamed; John W Bigbee; Tomasz Kordula; Hope Richard; Kabirullah Lutfy; Carmen Sato-Bigbee
Journal:  Glia       Date:  2017-09-14       Impact factor: 7.452

4.  An accessible and high-throughput strategy of continuously monitoring apoptosis by fluorescent detection of caspase activation.

Authors:  Kelly M Hanson; Jacob N Finkelstein
Journal:  Anal Biochem       Date:  2018-10-24       Impact factor: 3.365

5.  Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala.

Authors:  H Pantazopoulos; M Markota; F Jaquet; D Ghosh; A Wallin; A Santos; B Caterson; S Berretta
Journal:  Transl Psychiatry       Date:  2015-01-20       Impact factor: 6.222

6.  Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling.

Authors:  Christine T Ferrara; Ping Wang; Elias Chaibub Neto; Robert D Stevens; James R Bain; Brett R Wenner; Olga R Ilkayeva; Mark P Keller; Daniel A Blasiole; Christina Kendziorski; Brian S Yandell; Christopher B Newgard; Alan D Attie
Journal:  PLoS Genet       Date:  2008-03-14       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.